The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer.
Dr. Frank Sinicrope
Advertisement
Articles by Dr. Frank Sinicrope
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer
2
Mariska Hargitay Honors Father Through Myeloma Awareness Effort
3
Changing Surveillance Routines Brings New Survivorship Challenges
4
Oncologist Answers Most Asked Questions About Colorectal Cancer
5